Alexion Pharmaceuticals Inc. (ALXN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 11,420 | 0.02 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 62.32% | 18,889 | 0.03 | |
| Q4 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 10,959 | 0.02 | |
| Q3 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 18.42% | 2,475 | 0.00 | |
| Q2 2020 | |||||
| ≡ | First Eagle Investment Management | Sell 100.00% | 50,000 | 0.02 | |
| Q1 2020 | |||||
| ≡ | Bill Miller - Miller Value Partners | Sell 100.00% | 388,380 | 1.51 | |
| Q4 2019 | |||||
| ≡ | Bill Miller - Miller Value Partners | Reduce 13.46% | 60,400 | 0.23 | |
| ≡ | Harry Burn - Sound Shore | Sell 100.00% | 444,850 | 2.78 | |
| Q1 2019 | |||||
| ≡ | Bill Miller - Miller Value Partners | Reduce 0.10% | 455 | 0.00 | |
| Q4 2018 | |||||
| ≡ | Bill Miller - Miller Value Partners | Reduce 0.15% | 690 | 0.00 | |
| ≡ | Harry Burn - Sound Shore | Reduce 13.02% | 50,850 | 0.31 | |
| Q1 2018 | |||||
| ≡ | Bill Miller - Miller Value Partners | Reduce 3.62% | 15,800 | 0.08 | |
| Q4 2017 | |||||
| ≡ | Bill Miller - Miller Value Partners | Reduce 1.70% | 7,560 | 0.04 | |
| ≡ | Daniel Loeb - Third Point | Sell 100.00% | 1,000,000 | 1.18 | |
| Q3 2017 | |||||
| ≡ | Bill Miller - Miller Value Partners | Reduce 1.40% | 6,300 | 0.04 | |
| ≡ | Daniel Loeb - Third Point | Reduce 20.00% | 250,000 | 0.30 | |
| Q3 2015 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 1,600 | 0.00 | |
| Q3 2012 | |||||
| ≡ | Thomas Russo - Gardner Russo & Quinn | Sell 100.00% | 717 | 0.00 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.